Charles Williams
Director of Finance/CFO at SURROZEN, INC.
Net worth: 23 157 $ as of 2024-03-30
Profile
Charles Williams is currently the Chief Operating & Financial Officer at Surrozen, Inc. He previously worked as the Director-Corporate & Business Development at MAP Pharmaceuticals LLC from 2008 to 2013, and as the Head-Corporate Development at Jazz Pharmaceuticals Plc from 2013 to 2020.
Mr. Williams completed his undergraduate degree at Cornell University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SURROZEN INC
0.07% | 2024-04-03 | 1,474 ( 0.07% ) | 23 157 $ | 2024-03-30 |
Charles Williams active positions
| Companies | Position | Start |
|---|---|---|
| SURROZEN, INC. | Director of Finance/CFO | 2020-10-31 |
Former positions of Charles Williams
| Companies | Position | End |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 2020-10-31 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 2012-12-31 |
Training of Charles Williams
| Cornell University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| SURROZEN, INC. | Health Technology |
| Private companies | 1 |
|---|---|
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
- Stock Market
- Insiders
- Charles Williams
